Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
uniQure B.V. (QURE)  
$4.69 0.01 (0.21%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 44,500,000
Market Cap: 208.71(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.39 - $22.2
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   uniQure is engaged in the field of gene therapy, focusing to develop single treatments for patients suffering from genetic and other diseases. Co. is developing etranacogene dezaparvovec, a gene therapy for patients with hemophilia B that is designed to restore Factor IX (FIX) activity, a protein for blood clotting. Etranacogene dezaparvovec includes an adeno-associated virus (AAV) 5 vector incorporating the FIX-Padua variant. Co. is also developing AMT-180 for hemophilia A, AMT-190 for fabry disease, and AMT-130 for huntington's disease. Co.'s AMT-150 is a one-time, intrathecally-administered, AAV gene therapy incorporating Co.'s miQURE™ silencing technology.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 53,265 53,265 74,223 229,905
Total Sell Value $339,844 $339,844 $555,147 $3,944,931
Total People Sold 3 3 4 13
Total Sell Transactions 3 3 5 43
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 336
  Page 10 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2020-01-15 4 AS $68.97 $275,880 D/D (4,000) 41,578 -8%     
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2020-01-15 4 OE $5.31 $21,240 D/D 4,000 45,578     -
   Soteropoulos Paula Director   –       •      –    2020-01-07 4 AS $72.18 $216,540 D/D (3,000) 5,352 -21%     
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-12-18 4 AS $69.94 $528,510 D/D (7,540) 367,451     -
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-12-18 4 OE $7.53 $55,263 D/D 7,339 374,991     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-12-16 4 AS $74.37 $298,356 D/D (4,000) 41,578     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-12-16 4 OE $5.31 $21,240 D/D 4,000 45,578     -
   Soteropoulos Paula Director   –       •      –    2019-12-13 4 AS $70.50 $141,000 D/D (2,000) 8,352     -
   Soteropoulos Paula Director   –       •      –    2019-12-13 4 OE $5.37 $10,740 D/D 2,000 10,352     -
   Soteropoulos Paula Director   –       •      –    2019-12-09 4 AS $67.50 $168,750 D/D (2,500) 8,352     -
   Soteropoulos Paula Director   –       •      –    2019-12-06 4 AS $63.69 $583,600 D/D (9,082) 10,852     -
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-11-20 4 AS $53.04 $429,951 D/D (8,000) 367,652     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-11-15 4 AS $51.99 $208,310 D/D (4,000) 41,578     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-11-15 4 OE $5.31 $21,240 D/D 4,000 45,578     -
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-10-23 4 AS $42.94 $345,781 D/D (8,000) 375,652     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-10-15 4 AS $42.35 $169,400 D/D (4,000) 41,578     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-10-15 4 OE $5.31 $21,240 D/D 4,000 45,578     -
   Gut Robert Chief Medical Officer   •       –      –    2019-09-19 4 S $47.16 $224,906 D/D (4,769) 35,378     -
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-09-18 4 AS $46.69 $378,486 D/D (8,000) 383,652     -
   Van Deventer Sander EVP, Research & Product Dev.   •       –      –    2019-09-17 4 A $0.00 $0 D/D 15,000 45,354     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-09-17 4 A $0.00 $0 D/D 15,000 41,578     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-09-16 4 AS $47.26 $189,040 D/D (4,000) 26,578     -
   Kuta Alexander Edward Iii Executive VP, Operations   •       –      –    2019-09-16 4 OE $5.31 $21,240 D/D 4,000 30,578     -
   Kapusta Matthew C CEO, CFO, Managing Director   •       •      –    2019-08-21 4 AS $56.48 $451,840 D/D (8,000) 391,230     -
   Kuta Alexander Edward Iii Executive VP, OperationsOffice   •       –      –    2019-08-20 3 IO $0.00 $0 D/D 0 26,578     -
  336 Records found
  Previous  10  11  12  13  14   
  Page 10 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us